CORRESPONDENCE
Sublingual immunotherapy affects transforming growth factor-β and nasal eosinophils
First published: 04 August 2010
No abstract is available for this article.
References
- 1
Scadding GW,
Shamji MH,
Jacobson MR et al. Sublingual grass pollen immunotherapy is associated with increase in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
Clin Exp Allergy
2010; 40: 598–606.
- 2
Ciprandi G,
Fenoglio D,
Cirillo I et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.
Ann Allergy Asthma Immunol
2005; 95: 38–44.
- 3
Cosmi L,
Santarlasci V,
Angeli R et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-g- and interleukin-10-production.
Clin Exp Allergy
2006; 36: 261–72.
- 4
O'Hehir RE,
Gardner LM,
De Leon MP et al. House dust mite sublingual immunotherapy.
Am J Respir Crit Care Med
2009; 180: 936–7.
- 5
Ciprandi G,
De Amici M,
Negrini S,
Marseglia GL,
Tosca MA.
TGF-β and IL-17 serum levels and specific immunotherapy.
Int Immunopharm
2009; 9: 1247–9.
- 6
Ciprandi G,
De Amici M,
Tosca MA,
Marseglia GL.
Serum TGF-β levels depend on allergen exposure in allergic rhinitis.
Int Arch Allergy
2009; 152: 66–70.
- 7
Ciprandi G,
De Amici M,
Tosca MA,
Marseglia GL.
Serum TGF-β levels depend on allergen exposure in allergic rhinitis.
Int Arch Allergy
2009; 152: 66–70.
- 8
Ciprandi G,
Fenoglio D,
Di Gioacchino M et al. Interferon-gamma may be an early marker of response to sublingual immunotherapy.
J Biol Reg
2008; 22: 169–73.
